CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 1,000 enrolled
Drug / intervention
Fluticasone furoate and fexofenadinedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00435461
NCT00435461Phase 4Completed
CompareCT.gov

A Comparison of Fluticasone Furoate Nasal Spray Versus Oral Fexofenadine in the Treatment of Seasonal Allergic Rhinitis

GlaxoSmithKline·interventional·Posted Feb 15, 2007·Updated Mar 7, 2018

In Brief

A Phase 4 clinical trial evaluating Fluticasone furoate and fexofenadine for Rhinitis, Allergic, Seasonal. Completed, enrolled 1,000 participants across 6 sites.

Detailed Summary

The primary objective of this study is to compare the nighttime symptom relief of fluticasone furoate nasal spray and oral fexofenadine

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRhinitis, Allergic, Seasonal
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 15, 2007
Enrollment StartDec 20, 2006
Primary CompletionFeb 1, 2007
Study CompletionFeb 28, 2007
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 19.4 years ago

Interventions

Fluticasone furoate and fexofenadinedrug

Fluticasone furoate and fexofenadine